(Q54447254)

29 May 2018

title

Immunogenicity and protective effect against murine cerebral neosporosis of recombinant NcSRS2 in different iscom formulations. (English)

1 reference

29 May 2018

author name string

Sunan Pinitkiatisakul

1

1 reference

29 May 2018

Mikaela Friedman

2

1 reference

29 May 2018

Maria Wikman

3

1 reference

29 May 2018

Jens G Mattsson

4

1 reference

29 May 2018

Karin Lövgren-Bengtsson

5

1 reference

29 May 2018

Stefan Ståhl

6

1 reference

29 May 2018

Anna Lundén

7

1 reference

29 May 2018

language of work or name

English

0 references

publication date

24 January 2007

1 reference

29 May 2018

published in

Vaccine

1 reference

29 May 2018

volume

25

1 reference

29 May 2018

issue

18

1 reference

29 May 2018

page(s)

3658-3668

1 reference

29 May 2018

Review of Neospora caninum and neosporosis in animals

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

Coyotes (Canis latrans) are definitive hosts of Neospora caninum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

Comparison of the biological characteristics of two isolates of Neospora caninum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

Immunisation of mice against neosporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

Immunity to experimental neosporosis in pregnant sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

Protection against vertical transmission in bovine neosporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

Prevention of vertical transfer of Neospora caninum in BALB/c mice by vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

Immunization of BALB/c mice with killed Neospora caninum tachyzoite antigen induces a type 2 immune response and exacerbates encephalitis and neurological disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

Reduced cerebral infection of Neospora caninum-infected mice after vaccination with recombinant microneme protein NcMIC3 and ribi adjuvant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

Reduced infection and protection from clinical signs of cerebral neosporosis in C57BL/6 mice vaccinated with recombinant microneme antigen NcMIC1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

Vaccination of mice against experimental Neospora caninum infection using NcSAG1- and NcSRS2-based recombinant antigens and DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

Protective efficacy of vaccination by recombinant vaccinia virus against Neospora caninum infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

Prevention of vertical transmission of Neospora caninum in BALB/c mice by recombinant vaccinia virus carrying NcSRS2 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

Immunization with native surface protein NcSRS2 induces a Th2 immune response and reduces congenital Neospora caninum transmission in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

Hydrophobic moeties in recombinant proteins are crucial to generate efficient saponin-based vaccine against Apicomplexan Babesia divergens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

General strategies for efficient adjuvant incorporation of recombinant subunit immunogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

Immunomodulation by iscoms, immune stimulating complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

ISCOMs: an adjuvant with multiple functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

In vivo and in vitro lipidation of recombinant immunogens for direct iscom incorporation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

Applying biotin-streptavidin binding for iscom (immunostimulating complex) association of recombinant immunogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

Immunisation of mice against neosporosis with recombinant NcSRS2 iscoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

Immunogenicity in rabbits and monkeys of influenza ISCOMs conjugated with repeated sequences of the Plasmodium falciparum antigen Pf155/RESA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

Application of iscom antigen preparations in ELISAs for diagnosis of Neospora and Toxoplasma infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

Neospora caninum: Identification of 19-, 38-, and 40-kDa Surface Antigens and a 33-kDa Dense Granule Antigen Using Monoclonal Antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

Characterization of Neospora caninum iscom antigens using monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

Cellular immune responses in cattle experimentally infected with Neospora caninum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

A competitive PCR assay for quantitative detection of Neospora caninum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

Neospora caninum: role for immune cytokines in host immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

Comparison of intracerebral parasite load, lesion development, and systemic cytokines in mouse strains infected with Neospora caninum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

Interferon-gamma and interleukin-12 mediate protection to acute Neospora caninum infection in BALB/c mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

Immune responses to Neospora caninum and prospects for vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

Neutralization of maternal IL-4 modulates congenital protozoal transmission: comparison of innate versus acquired immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

Introduction to avidin-biotin technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.074

10.1016/J.VACCINE.2007.01.074

7 January 2021

Identifiers

DOI

1 reference

29 May 2018

1 reference

29 May 2018